Blood clotting secrets in AML: new study aims to predict bleeding risks
NCT ID NCT07343687
First seen Jan 19, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study will look at blood clotting problems in 80 adults newly diagnosed with acute myeloid leukemia (AML) who are about to receive strong chemotherapy. The goal is to measure changes in clotting before and after treatment to better understand bleeding risks. This is an observational study, not a test of a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.